α-Thiolamines such as cysteine and cysteamine act as effective transglycating agents due to formation of irreversible thiazolidine derivatives

Medical Hypotheses

Volumn 66, Issue 4, 2006, Pages 698-707

  Szwergold, B S ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYSTEINE; FRUCTOSE PHOSPHATE; GLUCOSE; GLUTATHIONE; MERCAPTAMINE; PHOSPHOLIPID; POLYAMINE; SCHIFF BASE; THIAZOLIDINE DERIVATIVE; THIOL DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; ENZYME GLYCOSYLATION; GAS CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MACROMOLECULE; MASS SPECTROMETRY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN MODIFICATION;

CYSTEAMINE; CYSTEINE; GLUCOSE; GLYCOSYLATION; THIAZOLES;

EID: 31844446930     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.10.029     Document Type: Article

References (44)

1. B.S. Szwergold Identification of a novel protein kinase activity specific for Amadori adducts on glycated proteins Diabetes 46 1997 108A
2. G. Delpierre Identification, cloning and heterologous expression of a mammalian fructosamine-3-kinase Diabetes 49 2000 1627 1634
3. B.S. Szwergold, S.K. Howell, and P.J. Beisswenger Human fructosamine-3-kinase [FN3K]: purification, sequencing, substrate specificity and evidence of activity in vivo Diabetes 50 2001 2139 2147
4. H. Kato, N. van Chuyen, T. Shinoda, F. Sekiya, and F. Hayase Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats Biochem Biophys Acta 1035 1990 71 76
5. M. Takahashi, J. Fujii, T. Teshima, K. Suzuki, T. Shiba, and N. Taniguchi Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression Gene 127 1993 247 253
6. K. Sato, A. Inazu, S. Yamaguchi, T. Nakayama, Y. Deyashiki, and H. Sawada Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase Arch Biochem Biophys 307 1993 286 294
7. M. Oimoni, F. Hata, N. Igaki, T. Nakamichi, S. Baba, and S. Kato Purification of a-ketoaldehyde dehydrogenase from the human liver and its possible significance in the control of glycation Experientia 45 1989 463 466
8. G. Delpierre, F. Collard, J. Fortpied, and E. Van Schaftingen Fructosamine-3-kinase is involved in an intracellular deglycation pathway in human erythrocytes Biochem J 365 2002 801 808
9. G. Delpierrre Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin J Biol Chem 279 2004 27613 27620
10. B.S. Szwergold, S.K. Howell, and P.J. Beisswenger Nonenzymatic glycation/enzymatic deglycation. A novel hypothesis on the etiology of diabetic complications Proceeding of the 7th international symposium on Maillard reaction vol. 1245C 2002 Elsevier Amsterdam/New York 143 152
11. A. Ceriello Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications Diab Nutr Met Clin Exp 12 1999 42 46
12. M.A. van Boekel The role of glycation in aging and diabetes mellitus Mol Biol Rep 15 1991 57 64
13. B.S. Szwergold Intrinsic toxicity of glucose due to non-enzymatic glycation is controlled in vivo by deglycation systems including FN3K-mediated deglycation of fructosamines and transglycation of aldosamines Med Hypotheses 65 2005 337 348
14. B.S. Szwergold, S.K. Howell, and P.J. Beisswenger J. Baynes V.M. Monnier J.M. Ames The Maillard reaction: eighth international symposium Ann NY Acad Sci 1043 2005 845 864
15. B.S. Szwergold Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases BBRC 336 2005 36 41
16. C.I. Neglia, H.J. Cohen, A.R. Garber, S.R. Thorpe, and J.W. Baynes Characterization of glycated proteins by 13C NMR spectroscopy. Identification of specific sites of protein modification by glucose J Biol Chem 260 1985 5406 5410
17. V.V. Mossine, G.V. Glinsky, and M.S. Feather The preparation and characterization of some Amadori compounds [1-amino-1-deoxy-d-fructose derivatives] derived from a series of aliphatic α-amino acids Carbohyd Res 262 1994 257 270
18. M. Kishimoto Sensitive, selective gas chromatographic-mass spectrometric analysis with trifluotroacetyl derivatives and a stable isotope for studying tissue sorbitol-producing activity J Chromatogr B 688 1997 1 10
19. W.B. Yao, M. Tomozawa, and K. Yukihiro Protective effect of glucose-cysteine adduct on the in situ perfused rat liver Amino Acids 12 1997 33 40
20. W.B. Yao, T. Abe, and Y. Kurozumi Effect of glucose-cysteine adduct as a cysteine prodrug in rats Amino Acids 12 1997 85 94
21. M. Wrobel, T. Ubuka, W.B. Yao, and T. Abe Effect of glucose-cysteine adduct on cysteine desulfuration in guinea pig tissues Physiol Chem Phys Med NMR 29 1997 11 14
22. M.S. Swamy, C. Tsai, A. Abraham, and E.C. Abraham Glycation mediated lens crystallin aggregation and cross-linking by various sugars and sugar phosphates in vitro Exp Eye Res 56 1993 177 185
23. B.S. Szwergold, S. Lal, A.H. Taylor, F. Kappler, B.Y. Su, and T.R. Brown 31P NMR evidence of an activated hexose-monophosphate shunt in hyperglycemic rat lenses in vivo Diabetes 44 1995 810 815
24. F.P. O'Harte, A.C. Penney, and P.R. Flatt Glycation of insulin by phosphorylated and nonphosphorylated reducing sugars Biochem Soc Trans 25 1997 150S
25. P.J. Thornalley Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options Int Rev Neurobiol 50 2002 37 57
26. D.A. Slatter, N.C. Avery, and A.J. Bailey Identification of a new cross-link and unique histidine adduct from bovine serum albumin incubated with malondialdehyde J Biol Chem 279 2004 61 69
27. A.S. Januszewski, N.L. Alderson, A.J. Jenkins, S.R. Thorpe, and J.W. Baynes Chemical modification of proteins during peroxidation of phospholipids J Lipid Res 46 2005 1440 1449
28. T. Hayashi, Y. Ohta, and M. Namiki Electron spin resonance spectral study on the structure of the novel free radical products formed by the reaction of sugars with amino acids or amines J Agri Food Chem 25 1977 1282 1287
29. B.J. Ortwerth, H. James, G. Simpson, and M. Linetsky The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxyosones Biochem Biophys Res Commun 245 1998 161 165
30. C.J. Mullarkey, D. Edelstein, and M. Brownlee Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes Biochem Biophys Res Commun 173 1990 932 939
31. Y. Keita, M. Michailova, and W. Kratzer Influence of penicillamine on the formation of early non-enzymatic glycation products of human serum proteins Int J Clin Pharmacol Ther Toxicol 30 1992 441 442
32. C.C. Hsu, H.F. Yen, M.C. Yin, C.M. Tsai, and C.H. Hsieh Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice J Nutr 134 2004 3245 3249
33. P. Odetti Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes Diabetes 52 2003 499 505
34. B. Ramamurthy, A.D. Jones, and L. Larsson Glutathione reverses early effects of glycation on myosin function Am J Physiol 285 2003 C419 C424
35. D. Verzola, M.B. Bertolotto, and B. Villaggio Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells J Invest Med 50 2002 443 451
36. A.R. Hipkiss Pluripotent protective effects of carnosine, a naturally occurring dipeptide Ann NY Acad Sci 854 1998 37 53
37. L. Tenneze, V. Daurat, and A. Tibi A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers Brit J Clin Pharmacol 47 1999 49 52
38. R. Kleta, and W.A. Gahl Pharmacological treatment of nephropathic cystinosis with cysteamine Exp Opin Pharmacother 5 2004 2255 2262
39. W.A. Gahl Early oral cysteamine therapy for nephropathic cystinosis Eur J Ped 162 Suppl. 1 2003 S38 S41
40. L. Vecsei, and E. Widerlov Preclinical and clinical studies with cysteamine and pantethine related to the central nervous system Prog Neuro-Psychopharmacol Biol Psych 14 1990 835 862
41. A.L. Jones Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review J Toxicol Clin Toxicol 36 1998 277 285
42. M.T. Marthaler, and P.A. Keresztes Evidence-based practice for the use of N-acetylcysteine DCCN - Dimensions Crit Care Nursing 23 2004 270 273
43. P. Kiefer, J. Vogt, and P. Radermacher From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine Crit Care Med 28 2000 3935 3936
44. M.L. Schilsky Treatment of Wilson's disease: what are the relative roles of penicillamine,trientine, and zinc supplementation? Curr Gastroenterol Rep 3 2001 54 59